Epstein‐Barr virus (EBV) nuclear antigen 1 (EBNA1) and latent membrane proteins (LMP)
are the only antigens consistently expressed in malignancies such as nasopharyngeal …

Two unusual characteristics of the memory response to the immunodominant Epstein-Barr
virus (EBV) epitope FLRGRAYGL, which associates with HLA B8, have provided an unique …

We investigated 49 acquired immunodeficiency syndrome-related lymphomas (ARLs) for
Epstein-Barr virus (EBV) by Southern blotting and in situ hybridization and, in positive cases …

In the present report, cytotoxic T lymphocyte (CTL) clones are described that display dual
specificity for one of two common human leukocyte antigens (HLA B14 or B35) as …

Epstein-Barr virus (EBV)-specific CTL clones were isolated that recognized A-type EBV
transformants but not B-type transformants. These A-type-specific CTL clones (HLA B8 …

A possible cofactor in human immunodeficiency virus (HIV) infection is the Epstein-Barr virus
(EBV), which is divided into two primary types that differ significantly in their transformation …

In this study, infectious Epstein‐Barr virus (EBV) shedding in the oropharynx and numbers of
virus‐infected B cells in the blood have been monitored in long‐term virus carriers receiving …

The production of synthetic MHC-peptide tetramers has revolutionized cellular immunology
by revealing enormous CD8+ T cell expansions specific for peptides from various …

Publisher Summary This chapter discusses the information obtained by the molecular
characterization of Epstein–Barr virus (EBV) diversity and explains its relevance for viral …

Development of a vaccine against Epstein‐Barr virus (HBV) is constrained by the latency
phenotypes adopted by different EBV‐associated diseases. Over the last few years an …